tiprankstipranks
Trending News
More News >
Pharmaust Limited (AU:NUZ)
ASX:NUZ
Australian Market

Pharmaust Limited (NUZ) Income Statement

Compare
26 Followers

Pharmaust Limited Income Statement

Last quarter (Q4 2022), Pharmaust Limited's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Pharmaust Limited's net income was $―. See Pharmaust Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22Jun 21Jun 20Jun 19Jun 18
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 3.07M$ 1.92M$ 2.95M$ 3.34M$ 2.58M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 314.93K$ 299.97K$ 274.64K$ 172.43K$ 118.61K
EBITDA
$ -1.30M$ -958.36K$ -968.86K$ -1.33M$ -2.37M
Operating Income
$ -2.75M$ -2.79M$ -2.17M$ -2.20M$ -2.92M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -1.71M$ -1.34M$ -1.36M$ -1.55M$ -2.52M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Pharmaust Limited Earnings and Revenue History